A decision by the UK government to end its financial support for the global fight against polio has placed decades of painstaking progress in jeopardy and drawn stark warnings about the risks to health security both abroad and at home.
In March 2026, ministers announced the withdrawal of funding for the Global Polio Eradication Initiative (GPEI) as part of its official development assistance allocations for 2026-2029, a move it stated was to “prioritise the most effective investments.” This ends a nearly four-decade commitment during which the UK contributed over £1.75 billion in flexible funding—a historic effort credited with helping to protect over 3 billion children and prevent more than 20 million cases of paralysis.
A fragile endgame thrown into doubt
The world is in what experts describe as the precarious “endgame” of polio eradication. After decades of coordinated international effort, case numbers have fallen by approximately 99%, an achievement built on vaccinating hundreds of millions of children annually, often through the world’s most fragile health systems. Strategic plans like the GPEI’s Polio Eradication Strategy 2022-2026 have charted the course for the final push to interrupt transmission and stop outbreaks.
Yet this final stretch is the most fragile. As memories of the disease fade and case numbers drop, the sophisticated systems for surveillance and outbreak response can falter or be scaled back precisely when vigilance is most critical. The GPEI has already been forced to cut its 2026 operational budget by 30% due to reduced donor support, leading to scaled-back activities in monitoring and response. This creates a dangerous opening for a virus that spreads easily and silently across borders.
The initiative faces a persistent funding shortfall. While a major pledging event in December 2025 saw global leaders commit $1.9 billion, narrowing a projected $1.7 billion gap to $440 million through 2029, the UK’s decision risks widening it again. The GPEI has stated that such reductions carry “significant risks” and will have a “real impact on the health of some of the most vulnerable children in the world.” It also sends, in the GPEI’s view, the wrong signal about the value placed on global health solidarity.
Direct consequences for the UK’s own health security
The threat is not abstract for the UK. As long as polio circulates anywhere, reintroduction remains a possibility. This was starkly demonstrated in 2022 when vaccine-derived poliovirus type 2 was detected in sewage samples from the London Beckton Sewage Treatment Works, indicating potential community transmission among under-immunised groups.
The response was complex and costly, requiring enhanced surveillance and a targeted vaccination campaign by the UK Health Security Agency. While the UK was removed from the World Health Organization’s list of polio ‘infected’ countries in December 2023 after 12 months without detection, the virus has reappeared in London’s wastewater since, including in March 2026. Ongoing circulation abroad, fueled by gaps in eradication efforts, means continued opportunities for the virus to reach British shores.
Experts argue that cutting support for global eradication does not save money but shifts the burden and accumulates risk, making expensive domestic responses more likely. The funding withdrawal is part of a broader reduction in UK foreign aid, which is set to fall from 0.5% to 0.3% of Gross National Income by 2027—a trend criticised by campaigners for potentially reversing hard-won gains in global health.
The UK’s own pledge history illustrates a rapid retreat. After committing up to £400 million for 2020-2023, disbursements fell from £70 million in 2020 to just £5 million in 2021, a 95% cut. The new pledge of £50 million over three years represents a 70% reduction from the 2019 commitment. This reversal comes as the GPEI, a partnership led by national governments with core partners including the WHO, UNICEF, and the CDC, executes an expanded budget of $6.9 billion for 2022-2029 to finish the job.
For health professionals and organisations like the ONE Campaign and Médecins Sans Frontières, the warning is clear: scaling back now, with the finish line in sight, undermines an epic achievement and compromises the health security of all nations, including the UK.
